It’s an exhilarating time for the hard-tech sector, particularly with the recent announcement that MIT.nano has more than doubled its roster of companies partaking in its START.nano program. As we head into 2025, an impressive 16 new startups have embarked on this high-impact journey.
START.nano plays an instrumental role in transforming lab-grown hard-tech innovations into formidable contenders in the marketplace. Startups participating in the program receive considerable advantages from MIT.nano, including discounted access to mutual facilities and a streamlined introduction to the MIT innovation ecosystem.
The fresh batch of startups have set their sights on resolving some of the world’s most urgent issues. Health, energy, climate, semiconductors, new materials, and quantum computing are among the many fields they are ambitiously delving into. START.nano Program Manager and MIT alumna, Joyce Wu, asserts that MIT.nano supports not only academic research but the commercial translation of it. She mentioned that “the START.nano accelerator supports early-stage companies from MIT and beyond with the tools and network they need for success.”
Born in 2021, START.nano aims to help hard-tech startups survive the daunting journey from the research lab to the competitive business world. Program participants take advantage of MIT.nano’s advanced laboratories and have the chance to exhibit at MIT conferences and exclusive events, such as the newly christened PITCH.nano competition.
Entrepreneurs involved in the program appreciatively acknowledge the integral role of START.nano in their success. Jason Gibson, CEO and co-founder of Quantum Formatics, gives credit to its combination of world-class infrastructure and supportive community. Likewise, Cynthia Liao, CEO and co-founder of Vertical Semiconductor, extols START.nano for its strategic advantage; it has expedited their development plans and significantly boosted their competitive edge.
Among the new cohort of 16 companies, five are spearheaded by MIT alumni, and three have ties with MIT. MIT’s immense influence is undeniable, with 49% of startups in START.nano being founded by MIT alumni.
The latest batch of START.nano startups includes Acorn Genetics, geared towards creating a “smartphone of sequencing” for quick, portable, and affordable genetic analysis, and Augmend Health, which leverages VR and AI to improve clinical data intelligence for specialty care. Another stand-out is Quantum Formatics, which employs AI to quicken the discovery of new superconductors.
START.nano now comprises more than 32 companies and 11 graduates, some of which have gone beyond the prototyping stages, entering commercialization. Check out the full list here.
If you’re on the hunt for AI automation solutions for your company, explore what implementi.ai can offer to streamline your operations and heighten productivity.
For more info, make sure to visit the oryginalny artykuł prasowy.
This website uses cookies.